换一批
换一批Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myeloma.
第一作者：
Jian,Cheng
第一单位：
Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany; Department of Hematology, Zhongda Hospital, Medical School, Southeast University, Nanjing, China.
作者：
主题词
成年人(Adult);老年人(Aged);抗HIV药(Anti-HIV Agents);苄胺类(Benzylamines);女(雌)性(Female);造血干细胞动员(Hematopoietic Stem Cell Mobilization);杂环化合物(Heterocyclic Compounds);人类(Humans);白细胞去除术(Leukapheresis);男(雄)性(Male);中年人(Middle Aged);多发性骨髓瘤(Multiple Myeloma);外周血干细胞移植(Peripheral Blood Stem Cell Transplantation);受体, CXCR4(Receptors, CXCR4);回顾性研究(Retrospective Studies)
DOI
10.1111/trf.12813
PMID
25117969
发布时间
2022-03-16
- 浏览7
Transfusion
275-83页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
